Seminar · Cambridge, United Kingdom
High Content and Phenotypic Screening
Health
Key numbers
- Editions on record
- 1first in 2017
About High Content and Phenotypic Screening
The development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications will be discussed at this SELECTBIO meeting. Topics for discussion include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening. Speakers include as Keynotes: - Leo Price, CEO, OcellO B.V - Lorenz Mayr, Vice President, AstraZeneca Ltd - Jeffrey Morgan, Professor, Brown University Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations. Visit the website for up-to-date information, including poster submissions, and registration details.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 25–26 Apr 2017 | Holiday Inn Cambridge Cambridge, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is High Content and Phenotypic Screening?
The next dates haven't been confirmed. The last edition we have on record was 25–26 Apr 2017.
Where is it held?
The last edition we have was at Holiday Inn Cambridge, Cambridge, United Kingdom.